Combined intraocular and systemic rituximab for ocular lymphoproliferative disorder with extranodal marginal zone lymphoma-type morphology after heart transplant.
J AAPOS
; 22(2): 159-161, 2018 04.
Article
en En
| MEDLINE
| ID: mdl-29408337
Post-transplant lymphoproliferative disorder (PTLD) has rarely been associated with ocular manifestations. We report a case of bilateral ocular involvement by PTLD with histopathologic features of extranodal marginal zone (MALT) lymphoma in an 8-year-old boy following orthotopic heart transplantation. The anterior segment disease was treated successfully using a combination of intraocular and systemic injections of humanized anti-CD20 antibody (rituximab).
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Complicaciones Posoperatorias
/
Neoplasias del Iris
/
Trasplante de Corazón
/
Linfoma de Células B de la Zona Marginal
/
Rituximab
/
Antineoplásicos Inmunológicos
/
Trastornos Linfoproliferativos
Tipo de estudio:
Etiology_studies
Límite:
Child
/
Humans
/
Male
Idioma:
En
Revista:
J AAPOS
Asunto de la revista:
OFTALMOLOGIA
/
PEDIATRIA
Año:
2018
Tipo del documento:
Article
Pais de publicación:
Estados Unidos